N. C. Allan

UK Medical Research Council randomised, multicentre trial of interferon-αn1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response

N. C. Allan, P.C.A. Shepherd, S Richards · The Lancet · 1995 · 404 citations · Full text

Hematological Malignancy, Oncology, Health Sciences +10

Malaria, anaemia and pregnancy

H. M. Gilles, John Lawson, M. Sibelas et al. · Annals of Tropical Medicine and Parasitology · 1969 · 228 citations

Malaria, Gynecology, Plasmodium Falciparum +18

Molecular heterogeneity in complete cytogenetic responders after interferon-α therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission

Andreas Hochhaus, Andreas Reiter, Anja Reichert Susanne Saußele et al. · Blood · 2000 · 184 citations

GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY, SICKLING, AND MALARIA IN AFRICAN CHILDREN IN SOUTH WESTERN NIGERIA

H. M. Gilles, K. A. Fletcher, R. G. Hendrickse et al. · The Lancet · 1967 · 143 citations

Malaria, Pediatrics, Glucose-6-phosphate-dehydrogenase Deficiency

Analysis of molecular breakpoint and m‐RNA transcripts in a prospective randomized trial of interferon in chronic myeloid leukaemia: no correlation with clinical features, cytogenetic response, duration of chronic phase, or survival

Patricia Shepherd, Ruth Suffolk, Jim Halsey et al. · British Journal of Haematology · 1995 · 124 citations